Latest news with #Taconic


Business Wire
2 days ago
- Business
- Business Wire
Taconic Biosciences Enters Into an Exclusive License Agreement With Helmholtz Munich to Expand Its CRISPR/Cas9 Gene Editing Services
RENSSELAER, N.Y.--(BUSINESS WIRE)-- Taconic Biosciences, a global leader in providing animal model solutions and services, entered into an exclusive license agreement with Helmholtz Munich, one of Germany's leading biomedical research centers, to provide preclinical researchers with advanced CRISPR gene editing services. By exclusively licensing Helmholtz Munich's groundbreaking gene editing techniques and applications, Taconic Biosciences strengthens its position as a leader in the commercialization of cutting-edge CRISPR gene editing services. Share Through this agreement, Taconic has acquired the exclusive rights to a patented CRISPR-based gene editing technology developed at Helmholtz Munich to improve the generation of genetically modified animal models for biomedical research. "Taconic is excited to expand our already extensive capabilities in CRISPR/Cas9 gene editing through this new partnership with Helmholtz Munich,' said Mike Garrett, Chief Executive Officer of Taconic Biosciences. 'This technology significantly enhances Taconic's ExpressMODEL ® platform to deliver high-quality, precise CRISPR/Cas9-generated custom animal models on an accelerated timeline to our customers." Taconic has been a pioneer in CRISPR/Cas9 gene editing services for over a decade and remains at the forefront of advanced gene-modification methodologies. By exclusively licensing Helmholtz Munich's groundbreaking gene editing techniques and applications, Taconic Biosciences strengthens its position as a leader in the commercialization of cutting-edge CRISPR gene editing services. "This agreement with Taconic will deepen our understanding of gene function by enabling the development of advanced, genetically engineered animal models," said Prof. Dr. Wolfgang Wurst, co-inventor of the licensed technology at Helmholtz Munich. "By combining our innovative CRISPR technology with Taconic's expertise in animal model generation and breeding, we aim to accelerate the creation of precise models that uncover the genetic basis of diseases — supporting scientific discovery and paving the way for future medical breakthroughs.' This partnership marks a significant milestone in Taconic's commitment to providing researchers with advanced tools for biomedical research. By integrating novel CRISPR/Cas9 technologies with proven expertise in model generation, the collaboration supports the rapid development of scientific breakthroughs and improved translation of genetic research into therapeutic innovation. To learn more about the ExpressMODEL ® CRISPR Platform and our Custom Model Generation Solutions, visit Or call 1-888-TACONIC (888-822-6642) in the US, +45 70 23 04 05 in Europe, or email info@ About Taconic Biosciences, Inc. Taconic Biosciences is a fully licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic provides the best animal solutions enabling customers to acquire, custom-generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, microbiome, immuno-oncology mouse models, and integrated model design and breeding services, Taconic operates service laboratories and breeding facilities in the U.S. and Europe, maintains distributor relationships in Asia and has global shipping capabilities to provide animal models almost anywhere in the world.
Yahoo
15-05-2025
- Yahoo
Police identify NJ, NY victims in fatal Taconic State Parkway crash in New Castle
State police have identified the four people killed, and the person critically injured, in Wednesday's two-car Taconic State Parkway crash in New Castle. Preliminary investigation indicates a 2014 Ram ProMaster van driven by Yader A. Reyes, 50, of Long Branch, New Jersey, was traveling south May 14 on the Taconic when it crossed the median into the northbound lanes, a New York State Police news release said. The van collided head on with the 2024 Honda Accord driven by Robert Violante, 45, of Granite Springs, whose car was traveling in the northbound passing lane. Taconic State Parkway accident: What we know now about May 14 fatal crash in Westchester Three passengers in the Ram ProMaster, all men from New Jersey — Odenis Balladares Martinez, 20, of Neptune; Harrison Mauricio Reyes Rivera, 34, of Long Branch; and Bryan Aguilar Castillo, 45, of Asbury Park were —pronounced dead at the scene. Violante, who was New Jersey's Bergenfield High School head football coach and a former star Somers High School athlete, was taken to a local hospital, where he succumbed to injuries and was pronounced dead, according to police, Reyes, the van's driver, is in critical condition at Westchester Medical Center, the police said Crash victim remembered: Bergenfield coach, former Somers HS athlete Rob Violante killed in Taconic crash The crash's cause is unknown and the investigation is ongoing, police said Thursday. Wednesday's crash, which occurred at mile marker 9.2 near exits 8 and 9, caused the van to overturn and catch fire, according to the police. A stretch of the Taconic was closed for hours after the crash and traffic was diverted off Exit 8. The state police ask that anyone who may have witnessed the crash or who has relevant information to contact the police at 845-677-7300. Contributing: lohud's Alexandra Rivera, Peter Carr, Ashley Fontones, and Jonathan Bandler; Darren Cooper of USA TODAY Network's This article originally appeared on Rockland/Westchester Journal News: Police ID 4 people killed, 1 injured in Taconic State Parkway crash

Yahoo
06-02-2025
- Business
- Yahoo
Mayor Adams aide under NYC Council probe didn't recuse from ex-employer dealings due to ‘miscommunication'
Nate Bliss, a senior aide to Mayor Adams, didn't recuse himself for years from city government business dealings with his ex-employer — and is now blaming the slipup on a 'miscommunication' with the city's ethics agency, the Daily News has learned. Bliss, who's facing a City Council probe over his ties to his ex-employer, Taconic Partners, wrote in a letter to Council investigators last Friday that four days before he left Taconic to join Adams' administration on Jan. 24, 2022, he contacted the Conflicts of Interest Board. Bliss, chief of staff to First Deputy Mayor Maria Torres-Springer, wrote his conversation focused on whether he needed to recuse himself from engaging in his government capacity with Taconic, which has significant city government business interests. Specifically, he wrote he disclosed to COIB he planned to while at City Hall continue holding stake in a Taconic-managed real estate investment fund. 'I was advised that a general conflict did not exist and that no formal recusal was necessary,' he wrote in the letter obtained by The News. But Bliss wrote he now believes 'there was a miscommunication with COIB' in 2022 about 'the nature' of his fund stake because he got different advice when he reached back out last month — after NBC4 first reported on it. '[I] was advised that I should formally recuse myself from any involvement in any Taconic project,' he wrote of a Jan. 22 exchange with COIB. 'I have and will continue to heed that guidance.' Bliss didn't elaborate on the alleged 2022 miscommunication, and Adams' office wouldn't comment. COIB Executive Director Carolyn Miller declined to comment specifically on Bliss, citing confidentiality rules. As first reported by The News, the Council Oversight and Economic Development Committees launched the Bliss probe last week after it emerged that his jump from Taconic to City Hall happened less than three months before Adams' administration picked Taconic to execute 'Innovation East,' a major redevelopment of the city's Manhattan public health lab. In an initial Jan. 27 request, the committees asked Bliss to, among other matters, furnish records about which properties the Taconic investment fund is invested in and how much money Bliss has been paid by it since joining the administration. Besides disclosing the recusal matter, Bliss wrote in Friday's letter he hasn't received money from the fund since 2022 because his 'carried interest' in it is part of a Taconic 'compensation package' that only generates a return upon liquidation. He said he doesn't know when that may happen. He wrote the fund has invested in six properties — four in Manhattan, one in Westchester County and one in New Jersey — but didn't identify them. He did say the lab Taconic's set to redevelop isn't one of them. Council Oversight Committee Chairwoman Gale Brewer told The News Wednesday she appreciated Bliss' quick response, but said he left questions unanswered. 'We need to know what these other properties are,' Brewer said of the six buildings. Brewer also called it 'strange' Bliss was first told to not recuse. 'We need to know if there was a change in the type of information he was providing [to COIB],' she said. Under local law, city officials are barred from working on issues related to private entities they hold financial interest in. Miller, the COIB executive director, also said officials must by law recuse themselves — not take meetings, receive documents or be copied on emails — about issues involving companies they have financial relationships with, and COIB can levy fines for violations. Bliss' letter says he has had 'no involvement while at City Hall with any project involving' Taconic. Taconic, though, listed Bliss in filings as a lobbying 'target' last year as it sought to secure permits from Adams' administration for Innovation East, which would turn the First Ave. lab into a 500,000 square-foot 'life sciences hub.' Referring to the lobbying disclosure, Bliss wrote he 'can find no record, nor do I recall any discussion or meeting regarding this or any other Taconic project.' The entity that officially picked Taconic for Innovation East was the Economic Development Corporation, which Bliss helps oversee as chief of staff. The EDC said last week Bliss didn't participate in that selection. Besides being chief of staff, Adams appointed Bliss in 2022 to chair the Land Development Corporation, an entity that must ultimately sign off on the Innovation East project. Adams spokeswoman Liz Garcia said Bliss' recusal will cover any LDC action on Innovation East. All but one of LDC's other four members work at the EDC or under Torres-Springer, with several of them reporting to Bliss. Garcia wouldn't say if those members will need recusals. Before any LDC moves, the Council needs to approve a zoning application undergirding Innovation East, and a vote's expected next week. Council Speaker Adrienne Adams' office said the Council can by law only consider 'land use merits' of Innovation East as part of next week's vote and that any 'conflicts of interest concerns' must be handled by committees.